Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
109 Cards in this Set
- Front
- Back
Cushing's syndrome: What are etiologies of Cushing’s syndrome? Is ACTH always elevated?
|
increased cortisol due to:, 1. Cushing’s disease (primary pituitary adenoma) increased ACTH, 2. Primary adrenal (hyperplasia/neoplasia) decreased ACTH, 3. Ectopic ACTH production (ie- small cell lung ca) increased ACTH, 4. Iatrogenic, decreased ACTH
|
|
Cushing's syndrome: Describe the clinical picture of Cushings.
|
HTN, wt gain, moon facies, truncal obesity, buffalo hump, hyperglycemia (insulin resistance), skin change (thinning, striae), osteoporosis, immune supression
|
|
Hyperaldosteronism: T/F Conn’s syndrome is secondary hyperaldosteronism.
|
False. Conn’s syndrome is primary hyperaldosteronism, caused by an aldosterone-secreting tumor. Results in HTN, hypokalemia, metabolic alkalosis, low plasma renin.
|
|
Hyperaldosteronism: Which hyperaldosteronism is associated with high plasma renin?
|
Secondary hyperaldosteronism. It is due to renal artery stenosis, chronic renal failure, CHF, cirrhosis, or nephrotic syndrome. Kidney perception of low intravascular volume results in an overactive renin-angiotensin sysem.
|
|
Hyperaldosteronism: What is the tx for hyperaldosteronism?
|
Spironolactone, a diuretic that works by acting as a aldosterone antagonist.
|
|
Addison's Disease: What characterizes addison’s disease? (which hormones are elevated or deficient)? Is it associated with HTN or hypotension?
|
Primary deficiency of aldosterone and cortisol due to adrenal atrophy, causing hypotension and skin hyperpigmentation. Adrenal atrophy, absence of hormone production, involves all 3 cortical divisions.
|
|
Addison's Disease: T/F In primary insufficiency decreased pituitary ACTH production is characterized by skin hyperpigmentation.
|
False: increased ACTH causes MSH activity & hyperpigmentation
|
|
Tumors of adrenal medulla: T/F Neuroblastoma is the most common tumor of adrenal medulla in adults.
|
False. Pheochromocytoma is the most common tumor of adrenal medulla in adults. It is derived from chromaffin cells (arise from neural crest). It is associated with neurofibromatosis MEN types II and III.
|
|
Tumors of adrenal medulla: Where does neuroblastoma occur?
|
Neuroblastoma is the most common tumor of adrenal medulla in children. It can occur anywhere along the sympathetic chain.
|
|
Tumors of adrenal medulla: AUTHOR
|
Jason Lee
|
|
Pheochromocytoma: secrete combination of two molecules
|
epinephrine and norepinephrine
|
|
Pheochromocytoma: epidemiology (rule of 10's)
|
10% malignant, 10% bilateral, 10% extra-adrenal, 10% calcify, 10% kids, 10% familial
|
|
Pheochromocytoma: symptoms - 5 P's
|
(elevated blood) Pressure, Pain (headache), Perspiration, Palpitations, Pallor/diaphoresis --> relapsing and remittant
|
|
Pheochromocytoma: elevations in two lab values
|
urinary VMA and serum catecholamines
|
|
Pheochromocytoma: association with two other endocrine diseases
|
MEN II and III
|
|
Pheochromocytoma: treatment
|
alpha-antagonists
|
|
Multiple Endocrine Neoplasia: type I (Wermer's syndrome) - 3 P's
|
Pancreas, Pituitary, and Parathyroid tumors
|
|
Multiple Endocrine Neoplasia: type II (Sipple's syndrome)
|
medullary carcinoma of thyroid, pheochromocytoma, parathyroid tumor, or adenoma
|
|
Multiple Endocrine Neoplasia: type III
|
medullary carcinoma of thyroid, pheochromocytoma, oral/intestinal ganglioneuromatosis
|
|
Hypothyroidism and hyperthyroidism: myxedema is prominent in which one
|
hypothyroidism
|
|
Hypothyroidism and hyperthyroidism: chest pain, palpitations, arrhythmias
|
hyperthyroidism
|
|
Hypothyroidism and hyperthyroidism: TSH is (increased/decreased) in primary hyperthyroidism? In primary hypothyroidism?
|
hyper - decreased, hypo - increased
|
|
Hypothyroidism and hyperthyroidism: Graves' disease involves autoantibodies with what mechanism of action?
|
stimulation of TSH receptors
|
|
Hypothyroidism and hyperthyroidism: three symptoms of Graves'
|
ophthalmopathy, pretibial myxedema, diffuse goiter
|
|
Hypothyroidism and hyperthyroidism: Graves' is a type __ hypersensitivity
|
type II
|
|
Hashimoto's thyroiditis: thyroid is (enlarged/not enlarged) and (tender/nontender)
|
enlarged, nontender
|
|
Hashimoto's thyroiditis: autoimmune antibodies directed against ---
|
microsomes
|
|
Hashimoto's thyroiditis: histology shows (type of cell) infiltrate
|
lymphocytes (with germinal centers)
|
|
Subacute thyroiditis (de Quervain's): self-limited (hyper/hypo)thyroidism following ---
|
hypothyroidism following flu-like illness
|
|
Subacute thyroiditis (de Quervain's): symptoms include
|
jaw pain, tender thyroid gland, early hyperthyroidism
|
|
Thyroid cancer: most common, good prognosis, "ground glass" nuclei, psammoma bodies
|
papillary carcinoma
|
|
Thyroid cancer: poor prognosis, uniform follicles
|
follicular carcinoma
|
|
Thyroid cancer: calcitonin producing (C cells), sheets of cells
|
medullary carcinoma (MEN II and III)
|
|
Thyroid cancer: older patients, horrible prognosis
|
undifferentiated/anaplastic
|
|
Cretinism: caused by a lack of dietary --- or defect in --- formation
|
iodine (endemic), T4 (sporadic)
|
|
Cretinism: symptoms include
|
pot-belly, paleness, puffy face, protuberant tongue, protruding umbilicus
|
|
Acromegaly: caused by excess --- in adults
|
growth hormone
|
|
Acromegaly: symptoms include
|
large furrowed tongue, deep voice, large hands and feet, coarse facial features
|
|
Acromegaly: in children, leads to ---
|
gigantism
|
|
Diabetes mellitus: acute symptoms common to both types
|
polydipsia, polyuria, polyphagia, weight loss
|
|
Diabetes mellitus: match: (DKA/hyperosmolar coma) with (type I/type II)
|
DKA=type I, hyperosmolar coma=type II
|
|
Diabetes mellitus: effects (increased/decreased) of insulin deficiency and glucagon excess on 1) glucose uptake, 2) protein catabolism, 3) lipolysis
|
1) decreased, 2) increased, 3) increased
|
|
Diabetes mellitus: increased plasma free fatty acids leads to
|
ketogenesis
|
|
Diabetes mellitus: hyperglycemia has what effect on blood volume and electrolytes
|
decreased volume (osmotic diuresis), electrolyte depletion
|
|
Diabetes mellitus: three chronic manifestations
|
retinopathy (hemorrhage, exudate, microaneurysm), nephropathy (nodular sclerosis), neuropathy (sensory, motor, autonomic)
|
|
Diabetes mellitus: sorbitol accumulation leads to what sequelae in the eye
|
cataracts, glaucoma
|
|
Diabetes mellitus: three tests - what are they? which one measures long-term glucose control?
|
fasting glucose, glucose tolerance test, HbA1c
|
|
Diabetes mellitus: AUTHOR
|
Jacob Pugsley
|
|
Type 1 - juvenile onset: % of diabetes
|
0.15
|
|
Type 1 - juvenile onset: Insulin necessary in treatment
|
Always
|
|
Type 1 - juvenile onset: Age
|
<30
|
|
Type 1 - juvenile onset: Association with obesity
|
No
|
|
Type 1 - juvenile onset: Genetic predisposition
|
weak, polygenic
|
|
Type 1 - juvenile onset: Association with HLA system
|
Yes (HLA-DR3 & 4)
|
|
Type 1 - juvenile onset: Glucose intolerance
|
Severe
|
|
Type 1 - juvenile onset: Ketoacidosis
|
Common
|
|
Type 1 - juvenile onset: B-cell numbers in the islets
|
decreased
|
|
Type 1 - juvenile onset: Serum insulin levels
|
decreased
|
|
Type 1 - juvenile onset: Classic symptoms of polyuria, polydipsia, thirst, weight loss
|
Common
|
|
Type 1 - juvenile onset: Theorized cause
|
viral or immune destruction of B cells
|
|
Type 2 - adult onset: % of diabetes
|
0.85
|
|
Type 2 - adult onset: Insulin necessary in treatment
|
Sometimes
|
|
Type 2 - adult onset: Age
|
>40
|
|
Type 2 - adult onset: Association with obesity
|
Yes
|
|
Type 2 - adult onset: Genetic predisposition
|
Strong, polygenic
|
|
Type 2 - adult onset: Association with HLA system
|
No
|
|
Type 2 - adult onset: Glucose intolerance
|
mild to moderate
|
|
Type 2 - adult onset: Ketoacidosis
|
Rare
|
|
Type 2 - adult onset: B-cell numbers in the islets
|
Variable
|
|
Type 2 - adult onset: Serum insulin levels
|
Variable
|
|
Type 2 - adult onset: Classic symptoms of polyuria, polydipsia, thirst, weight loss
|
Sometimes
|
|
Type 2 - adult onset: Theorized cause
|
increased resistance to insulin
|
|
Diabetic Ketoacidosis (type 1): What precipitates this
|
Increase in insulin requirements from increase in stress (e.g. infection)
|
|
Diabetic Ketoacidosis (type 1): Ketone bodies from where
|
Excess fat breakdown, increase ketogenesis from increased free fatty acids which are made into ketone bodies
|
|
Diabetic Ketoacidosis (type 1): Signs/Symptoms
|
Kussmaul respirations (rapid/deep breathing), hyperthermia, nausea/vomiting, abdominal pain, psychosis/dementia, dehydration, fruity breath odor
|
|
Diabetic Ketoacidosis (type 1): Labs
|
Hyperglycemia, high H+, low HCO3- (anion gap metabolic acidosis), high blood ketone levels, leukocytosis
|
|
Diabetic Ketoacidosis (type 1): Complications
|
Life threatening mucormycosis, Rhizopus infection, cerebral edema, cardiac arrhythimias, heart failure
|
|
Diabetic Ketoacidosis (type 1): Treatment
|
Fluids, insulin, and potassium; glucose if necessary to prevent hypoglycemia.
|
|
Diabetes insipidus: summary
|
intensive thirst, polyuria, inability to concentrate urine with fluid constriction owing to lack of ADH (central DI) or to lack of renal response to ADH (nephrogenic DI). Caused by lithium or demeclocycline
|
|
Diabetes insipidus: Findings
|
Urine specific gravity < 1.006; serum osmolality > 290 mOsm/L
|
|
Diabetes insipidus: Treatment
|
adequate fluid intake; Central DI - intranasal desmopressin (ADH analog); nephrogenic DI - hydrochlorothiazide, indomethacin, or amiloride
|
|
SIADH: what does it stand for
|
Syndrome of inapropriate ADH
|
|
SIADH: finds
|
1) excess water retention 2) hyponatremia [may lead to seizures - correct slowly] 3) urine osmolarity > serum osmolarity
|
|
SIADH: causes
|
1) Ectopic ADH [small cell lung cancer] 2) CNS disorders/head trauma 3) pulmonary disease 4) Drugs
|
|
Hyperparathyroidism: What causes primary hyperparathyroidism?
|
Usually an adenoma
|
|
Hyperparathyroidism: What are the findings of primary disease?
|
hypercalcemia, hypercalciuria, hypophosphatemia, high parathyroid hormone, high cAMP in urine; often asymptomatic, may present with weakness and constipation
|
|
Hyperparathyroidism: what is osteitis fibrosa cystica? (von Recklinghausen's syndrome)
|
cystic bone spaces filled with non-neoplastic fibrous tissue
|
|
Hyperparathyroidism: What causes secondary hyperparathyroidism?
|
low serum Ca++, most often chronic renal disease.
|
|
Hyperparathyroidism: What are the findings of secondary hyperparathyroidism?
|
hypocalcemia, hyperphosphatemia, high parathyroid hormone
|
|
Hypoparathyroidism: findings
|
hypocalcemia, tetany.
|
|
Hypoparathyroidism: causes
|
accidental surgical excision (thyroid surgery) or DiGeorge syndrome
|
|
Hypoparathyroidism: note: pseudohypoparathyroidism
|
autosomal recessive kidney unresponsiveness to PTH. Hypocalcemia, shortened 4th/5th digits, short stature
|
|
Carcinoid syndrome: frequency
|
rare
|
|
Carcinoid syndrome: cause
|
carcinoid tumors (neuroendocrine cells), especially those of the small bowel; they secrete high levels of serotonin (5-HT) that does not get metabolized by the liver due to liver metastases.
|
|
Carcinoid syndrome: symptoms
|
recurrent diarhea, cutaneous flushing, asthmatic wheezing, and right-sided valvular disease.
|
|
Carcinoid syndrome: most common tumor of what?
|
apendix
|
|
Carcinoid syndrome: lab
|
high 5-HIAA in urine
|
|
Carcinoid syndrome: Rule of 1/3s:
|
1/3 metastasize; 1/3 present with second malignancy; 1/3 multiple
|
|
Carcinoid syndrome: Treatment?
|
Octreotide
|
|
Carcinoid syndrome: What is this medication?
|
synthetic octapeptide analog of somatostatin (growth hormone-inhibiting hormone)
|
|
Zollinger-Ellison syndrome: What kind of tumor causes this?
|
Gastrin secreting tumor (usually) of the pancreas
|
|
Zollinger-Ellison syndrome: what does it cause?
|
recurrent ulcers
|
|
Zollinger-Ellison syndrome: may be associated with what?
|
MEN type I
|
|
Osteoporosis: what is this?
|
reduction in bone mass in spite of normal bone mineralization
|
|
Osteoporosis: what characterizes type 1?
|
Postmenopausal (10-15 years after menopause); increased bone reabsorption due to low estrogen levels. Treated with estrogen replacement
|
|
Osteoporosis: what characterizes type 2?
|
Senile osteoporosis - affects men and women > 70 y/o
|
|
Osteoporosis: what races are affected most?
|
whites>blacks>asians
|
|
Osteoporosis: symptoms of vertebral crush fractures
|
acute back pain, loss of height, kyphosis
|
|
Osteoporosis: other
|
distal radius (Colles') fracures, vertebral wedge fracures.
|